Programme

Keywords
PDF version

Wed 23 Oct

10:00

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

11:50

Advances in drug treatment

to
Auditorium II
Oral presentation session

Sex, gender and diversity in drugs

to
Auditorium IV
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

14:20

Neuroscience and cognition

to
Auditorium III
Short communication session

Challenge of measuring use and impact of cannabinoids

to
Room 1.07
Oral presentation session

Methods and measurement

to
Room 1.08
Short communication session

16:00

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Conceptualising health and harms

to
Room 1.08
Short communication session

17:50

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

19:30

Why are we not doing better at reducing drug-related deaths?

to
Auditorium I
Big debate

Thu 24 Oct

11:50

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Challenges, threats, and opportunities in addiction publishing today

to
Room 1.05
Oral presentation session

Contemporary issues

to
Room 1.08
Oral presentation session

16:00

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

From genes to brains

to
Room 1.06
Short communication session

Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain

to
Room 1.08
Oral presentation session

How to respond to real-time drug alerts in European countries ?

to
Room 1.15
Workshop

17:50

Mixed methods for understanding drug use

to
Auditorium III
Oral presentation session

Substance use and mental health in treatment settings

to
Auditorium VII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

Hospital-based treatments

to
Room 5B
Oral presentation session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

Fri 25 Oct

11:50

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Support for the addiction workforce

to
Room 1.07
Oral presentation session

14:20

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Impact of drug policy on drug production & markets

to
Room 5B
Oral presentation session